Synthesis and Spectroscopic Characterization of Some Transition Metal Complexes of 4-Nitro-N-(2-oxo-1,2-dihydropyrimidin-4-ylcarbamothioyl) benzamide (NPB)
DOI:
https://doi.org/10.46966/msjar.v7i2.371Keywords:
NPB, transition metal complexes, spectroscopic characterization, octahedral geometry, FT-IR/NMR/UV-Vis, magnetic and conductivity studiesAbstract
An isothiocyanate derivative was reacted with cytosine under appropriate reaction conditions to create 4-nitro-N-(2-oxo-1,2-dihydropyrimidin-4-ylcarbamothioyl)benzamide (NPB), a novel ligand. A number of analytical and spectroscopic methods, including as elemental analysis, ¹H NMR, ¹³C NMR, FT-IR, as well as UV–visible spectroscopy, were used to purify and characterize the synthesized ligand. These methods verified the ligand's functional groups and suggested molecular structure. The ligand was then reacted with various divalent metal ions to create a range of transition metal complexes. To ascertain the complexes' structural and electrical characteristics, conductivity experiments, FT-IR spectroscopy, UV-visible spectroscopy, along with magnetic susceptibility investigations were used. Through the use of suitable donor atoms, the ligand and metal ions were successfully coordinated, according to the analytical & spectral data. All complexes were isolated as stable crystalline solids exhibiting different colors depending on the metal ion involved. It was discovered that the metal-to-ligand molar ratio was 1:2, which translates to a (ligand: metal) ratio of 2:1. An octahedral geometry was suggested for the synthesized compounds based on the spectral and analytical data that were obtained. The complexes' overall molecular formula is [M(NPB)₂Cl₂], where M²⁺ = Mn, Co, Ni, Cu, Zn, Cd, & Hg.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Thuraya abdul kader , Zahra Mohamed Abase, Basima Muhsen Sarhan

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















